North America - United States • Finance

WilmerHale

More informationMore information

The debt finance practice at WilmerHale focuses on the borrower side, regularly handling matters for mid-market private equity firms, emerging life sciences and technology companies, as well as investment-grade clients.  The team is led by practice head Justin Ochs from Washington DC. The team is supported by Denver-based Chalyse Robinson, who has particular expertise in acquisition financings and debt finance transactions; Nathan Moore, also in Denver who was promoted to partnership in January 2023 and regularly takes on matters in the distressed space and royalty financings for biotech companies and Boston-based Brandt Tierney who has experience handling matters across the financial services, life sciences and technology sectors.  

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Chalyse Robinson is one of our strongest commercial lending legal advisor relationships. Chalyse differentiates herself in the market by staying on top of the market and technical trends but is also very commercial to see the forest through the trees. She always helps us reach great business outcomes! ’

  • ‘Experienced and diligent with a deep knowledge of subject matter’

  • ‘Justin Ochs- superior insight and analysis Nathan Moore- consistently outperforms competitors’

  •  

Key clients

  • Tessian Inc.
  • Eastman Chemical Company
  • PTC Therapeutics, Inc.
  • Mountaingate Capital Management, L.P.
  • Eldridge Industries, LLC
  • The Depository Trust & Clearing Corporation and National Securities Clearing Corporation
  • Analog Devices, Inc.
  • Kadant, Inc.
  • Melinta Therapeutics, Inc.
  • Wilmington Savings Fund Society, FSB

Work highlights

  • Represented Eastman Chemical Company in its inaugural $500m green bond offering – the first investment-grade US dollar-denominated senior unsecured green bond offering by a US issuer in the chemical sector.
  • Represented PTC Therapeutics in its agreement with Royalty Pharma to monetize PTC’s remaining interests in its Evrysdi royalty stream for up to $1.5bn – one of the largest-ever public royalty financing deals.
  • Represented The Depository Trust & Clearing Corporation and its subsidiary, National Securities Clearing – the premier provider of clearing and settlement services to the financial markets – in a renewal of their $11.395 billion 364-day revolving credit facility.

Practice head

The lawyer(s) leading their teams.

Justin Ochs